BKM Wealth Management LLC increased its position in shares of Aflac Incorporated (NYSE:AFL – Free Report) by 1.7% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 23,887 shares of the financial services provider’s stock after purchasing an additional 402 shares during the period. Aflac makes up approximately 1.0% of BKM Wealth Management LLC’s portfolio, making the stock its 25th largest position. BKM Wealth Management LLC’s holdings in Aflac were worth $2,471,000 at the end of the most recent quarter.
A number of other hedge funds have also recently added to or reduced their stakes in the company. Spinnaker Trust boosted its holdings in Aflac by 2.7% in the 3rd quarter. Spinnaker Trust now owns 3,620 shares of the financial services provider’s stock worth $405,000 after acquiring an additional 95 shares during the period. Phillips Wealth Planners LLC lifted its position in shares of Aflac by 1.5% during the fourth quarter. Phillips Wealth Planners LLC now owns 6,553 shares of the financial services provider’s stock worth $662,000 after purchasing an additional 100 shares in the last quarter. Raleigh Capital Management Inc. boosted its stake in shares of Aflac by 23.2% in the fourth quarter. Raleigh Capital Management Inc. now owns 531 shares of the financial services provider’s stock valued at $55,000 after purchasing an additional 100 shares during the period. New Century Financial Group LLC grew its holdings in Aflac by 2.5% during the 3rd quarter. New Century Financial Group LLC now owns 4,198 shares of the financial services provider’s stock valued at $469,000 after purchasing an additional 101 shares in the last quarter. Finally, Covestor Ltd increased its stake in Aflac by 41.8% during the 3rd quarter. Covestor Ltd now owns 363 shares of the financial services provider’s stock worth $41,000 after buying an additional 107 shares during the period. Institutional investors and hedge funds own 67.44% of the company’s stock.
Insider Activity at Aflac
In other Aflac news, EVP Audrey B. Tillman sold 24,744 shares of the business’s stock in a transaction on Friday, December 27th. The stock was sold at an average price of $103.40, for a total transaction of $2,558,529.60. Following the completion of the transaction, the executive vice president now owns 222,618 shares in the company, valued at approximately $23,018,701.20. The trade was a 10.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.90% of the stock is owned by insiders.
Aflac Price Performance
Aflac (NYSE:AFL – Get Free Report) last issued its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. As a group, sell-side analysts expect that Aflac Incorporated will post 6.95 earnings per share for the current year.
Aflac Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 3rd. Investors of record on Wednesday, February 19th will be issued a $0.58 dividend. This represents a $2.32 dividend on an annualized basis and a yield of 2.24%. This is a positive change from Aflac’s previous quarterly dividend of $0.50. The ex-dividend date of this dividend is Wednesday, February 19th. Aflac’s dividend payout ratio is 20.83%.
Analysts Set New Price Targets
AFL has been the subject of several recent analyst reports. Keefe, Bruyette & Woods lowered their target price on Aflac from $107.00 to $104.00 and set a “market perform” rating for the company in a research note on Wednesday, February 12th. BMO Capital Markets started coverage on Aflac in a research note on Thursday, January 23rd. They set a “market perform” rating and a $111.00 price objective for the company. Truist Financial upped their target price on Aflac from $100.00 to $105.00 and gave the company a “hold” rating in a research report on Friday, November 1st. Barclays decreased their price target on shares of Aflac from $98.00 to $95.00 and set an “underweight” rating for the company in a research report on Friday, February 7th. Finally, Evercore ISI cut their price target on shares of Aflac from $104.00 to $102.00 and set an “underperform” rating on the stock in a report on Wednesday, December 4th. Two investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have issued a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $103.00.
View Our Latest Report on Aflac
About Aflac
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Further Reading
- Five stocks we like better than Aflac
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Airbnb’s Earnings: Sky High Results, Grounded Guidance?
- Short Selling: How to Short a Stock
- Kyndryl Soars on AI, Cybersecurity Growth—What’s Next?
- About the Markup Calculator
- Conflicting Signals: Tempus AI’s Stock Market Rally
Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFL – Free Report).
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.